Correlation of BPD with placental pathology is important for clarification of the multifactorial pathogenesis of BPD; however, previous reports have yielded varying results. We report placental findings in no/mild BPD compared to moderate/severe BPD, and with and without pulmonary hypertension (PH).
Methods
Eligible infants were 230/7-276/7 weeks gestational age. BPD was defined by the need for oxygen at ≥28 days with severity based on need for respiratory support at ≥36 weeks. Acute and chronic inflammatory placental lesions and lesions of maternal and fetal vascular malperfusion were examined.
Results
Of 246 eligible infants, 146 (59%) developed moderate/severe BPD. Thirty-four (23%) infants developed PH, all but 1 being in the moderate/severe BPD group. Chronic deciduitis (32% vs 16%, P = .003), chronic chorioamnionitis (23% vs 12%, P = .014), and ≥ 2 chronic inflammatory lesions (13% vs 3%, P = .007) were more frequent in the moderate/severe BPD group. Development of PH was associated with placental villous lesions of maternal vascular malperfusion (30% vs 15%, P = .047).
Conclusions
The association of chronic inflammatory placental lesions with BPD severity has not been previously reported. This supports the injury responsible for BPD as beginning before birth in some neonates, possibly related to cytokines associated with these chronic inflammatory lesions.
YoonBHRomeroRKimKS, et al.
A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1999;
181(4):773–779.
2.
YoonBHRomeroRJunJK, et al.
Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997;
177(4):825–830.
3.
GhezziFGomezRRomeroR, et al.
Elevated interleukin-8 concentration in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol. 1998;
78(1):5–10.
4.
BagchiAViscardiRMTaciakV, et al.
Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994;
36(2):244–252.
5.
GaringoATesorieroLCayabyabR, et al.
Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia.Pediatr Res. 2007;
61(2):197–202.
6.
OeiJLuiKWangHHenryR.Decreased interleukin-10 in tracheal aspirates from preterm infants developing chronic lung disease. Acta Paediatr. 2002;
91(11):1194–1199.
7.
JonesCACayabyabRBKwongYC, et al.
Undetectable interleukin-10 and persistent interleukin- expression early in hyaline membrane disease: a possible development basis for the predisposition to chronic lung inflammation in preterm newborns.Pediatr Res. 1996;
39(6):966–975.
8.
McGowanEKostadinovSMcLeanK, et al.
Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk.Pediatr Res. 2009;
66(4):455–460.
9.
WaterbergKLDemersLMScottSMMurphyS.Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;
97(2):210–215.
10.
ViscardiRMMuhumuzaCKRodriguezA, et al.
Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res. 2004;
55(6):1009–1017.
11.
RedlineRWWilson-CostelloDHackM.Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants.Pediatr Res. 2002;
52(5):713–719.
12.
KentADahlstromJE.Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health. 2004;
40(7):356–359.
13.
HartlingLLiangYLacaze-MasmonteilT.Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review. Arch Dis Child Neonatal Ed. 2012;
97(1):F8–F17.
14.
BoseCVan MarterLJLaughonM, et al.
Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.Pediatrics. 2009:
124(3):e450–e458.
15.
CheckJGotteinerNLiuX, et al.
Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol. 2013:
33(7):553–557.
16.
OzkanHCetinkayaMKoksalN.Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia.J Matern Fetal Neonatal Med. 2012;
25(12):2681–2685.
17.
MestanKKCheckJMinturnL, et al.
Placental pathologic changes in maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. Placenta. 2014;
35(8):570–574.
18.
KhongTYMooneyEEArielI, et al.,
Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement.Arch Pathol Lab Med. 2016;
140(7):698–713.
19.
SharmaAXinYChenXSoodBG.Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants. Pediatr Neonatol. 2020;
61(3):290–299.
20.
JobeAHBancalariE.Bronchopulmonary dysplasia.Am J Respir Crit Care Med. 2001;
163(7):1723–1729.
21.
KimCJRomeroRKusanovicJP, et al.
The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol. 2010;
23(7):1000–1011.
22.
KhongTYBendonRWQureshiF, et al.
Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol. 2000;
31(3):292–295.
23.
KimCJRomeroRChaemsaithongPKimJ-S.Chronic inflammation in the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol. 2015;
213(4 suppl):S53–S69.
24.
KrausFTRedlineRWGersellDJNelsonDMDickeJM.Inflammation and Infection. Placental Pathology: Atlas of Non-Tumor Pathology (First Series, Fascicle 3).
Washington, DC:
American Registry of Pathology; 2004:75–115.
25.
LeeJHRomeroRXuY, et al.
Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.Am J Reprod Immunol. 2011;
66(6):510–526.
26.
LeeJHRomeroRXuY, et al.
A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One. 2011;
6(2):e16806.
27.
LeeJKimJ-SParkJW, et al.
Chronic chorioamnionitis is the most common placental lesion in late preterm birth. Placenta. 2013;
34(8):681–689.
28.
LeeJYHongJ-SKimEN, et al.
Placental C4d as a common feature of chromosomally normal and abnormal miscarriages. Virchows Arch. 2014;
464(5):613–620.
29.
RedlineRWZaragozaMHassoldT.Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum Pathol. 1999;
30(1): 93–100.
30.
PacoraPChaiworapongsaTMaymonE, et al.
Funisitis and chorionic vasculitis: the histologic counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;
11(1):18–25.
31.
JanevicTZeitlinJAugerN, et al.
Association of race/ethnicity with very preterm neonatal morbidities.JAMA Pediatrics. 2018;
172(11):1061.
32.
RyanRMFengRBazacliuC, et al. Black race is associated with a lower risk of bronchopulmonary dysplasia. J Pediatr. 2019;
207:130–135.e132.
